References:
1- Ashurst, John, and Megan Wasson. ”Methemoglobinemia: a systematic
review of the pathophysiology, detection, and treatment.” Delaware
medical journal 83.7 (2011): 203-208.
2- Alanazi, Menyfah Q. ”Drugs may be induced methemoglobinemia.” J
Hematol Thrombo Dis 5.3 (2017): 1-5.
3- Kielhofner, Marcia A. ”Trimethoprim-sulfamethoxazole:
pharmacokinetics, clinical uses, and adverse reactions.” Texas Heart
Institute Journal 17.2 (1990): 86.
4- Skold, Anna, Dominique L. Cosco, and Robin Klein. ”Methemoglobinemia:
pathogenesis, diagnosis, and management.” South Med J 104.11 (2011):
757-761.
5- Rino, Pedro Bonifacio, et al. ”Ascorbic acid for the treatment of
methemoglobinemia: the experience of a large tertiary care pediatric
hospital.” American journal of therapeutics 21.4 (2014): 240-243.
6- Lopez, A., et al. ”Methaemoglobinaemia secondary to treatment with
trimethoprim and sulphamethoxazole associated with inhaled nitric
oxide.” Acta Paediatrica (Oslo, Norway: 1992) 88.8 (1999): 915-916.
7- Jakobson, B., and A. Nilsson. ”Methemoglobinemia associated with a
prilocaine‐lidocaine cream and trimetoprim‐sulphamethoxazole. A case
report.” Acta anaesthesiologica scandinavica 29.4 (1985): 453-455.
8- Carroll, Timothy G., and Megan G. Carroll. ”Methemoglobinemia in a
pediatric oncology patient receiving sulfamethoxazole/trimethoprim
prophylaxis.” The American journal of case reports 17 (2016): 499.
9- Radhakrishnan, Nita, and Ruchi Rai. ”Cotrimoxazole-induced
Methemoglobinemia.” Indian pediatrics 54.9 (2017): 786-787.